Sponsorship of oncology clinical trials in the United States according to age of eligibility

by Dylan V. Neel, David S. Shulman, Clement Ma, Florence Bourgeois, Steven G. DuBois
Published 2020-07-01

Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death.

by Mellone N Marchong, Christine Yurkowski, Clement Ma, Clarellen Spencer, Sanja Pajovic, Brenda L Gallie
Published 2010-04-01

Off‐label prescribing of targeted anticancer therapy at a large pediatric cancer center

by Mir Lim, David S. Shulman, Holly Roberts, Anran Li, Jessica Clymer, Kira Bona, Hasan Al‐Sayegh, Clement Ma, Steven G. DuBois
Published 2020-09-01

Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology

by David S. Shulman, Lulla V. Kiwinda, Stacey Edwards, Catherine M. Clinton, Sarah Hunt, Lianne Greenspan, Kristen D. Lawler, Gregory Reaman, Hasan Al‐Sayegh, Kira Bona, Allison F. O'Neill, Suzanne Shusterman, Katherine A. Janeway, Andrew E. Place, Susan N. Chi, Clement Ma, Steven G. DuBois
Published 2021-04-01